1043 related articles for article (PubMed ID: 17011596)
1. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
2. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons.
Aracava Y; Pereira EF; Maelicke A; Albuquerque EX
J Pharmacol Exp Ther; 2005 Mar; 312(3):1195-205. PubMed ID: 15522999
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2004 Sep; 310(3):933-42. PubMed ID: 15121761
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
5. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
6. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
Unger C; Svedberg MM; Yu WF; Hedberg MM; Nordberg A
J Pharmacol Exp Ther; 2006 Apr; 317(1):30-6. PubMed ID: 16354790
[TBL] [Abstract][Full Text] [Related]
7. Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
Oh MM; Wu WW; Power JM; Disterhoft JF
Neuroscience; 2006; 137(1):113-23. PubMed ID: 16242849
[TBL] [Abstract][Full Text] [Related]
8. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
9. Synapse- and subtype-specific modulation of synaptic transmission by nicotinic acetylcholine receptors in the ventrobasal thalamus.
Nagumo Y; Takeuchi Y; Imoto K; Miyata M
Neurosci Res; 2011 Mar; 69(3):203-13. PubMed ID: 21145925
[TBL] [Abstract][Full Text] [Related]
10. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
11. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
[TBL] [Abstract][Full Text] [Related]
12. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478
[TBL] [Abstract][Full Text] [Related]
14. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
Gilling KE; Jatzke C; Parsons CG
Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
[TBL] [Abstract][Full Text] [Related]
15. Bis(7)-tacrine prevents glutamate-induced excitotoxicity more potently than memantine by selectively inhibiting NMDA receptors.
Liu YW; Li CY; Luo JL; Li WM; Fu HJ; Lao YZ; Liu LJ; Pang YP; Chang DC; Li ZW; Peoples RW; Ai YX; Han YF
Biochem Biophys Res Commun; 2008 May; 369(4):1007-11. PubMed ID: 18328812
[TBL] [Abstract][Full Text] [Related]
16. Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.
Lorrio S; Negredo P; Roda JM; García AG; López MG
Brain Res; 2009 Feb; 1254():128-37. PubMed ID: 19103181
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Enz A; Gentsch C
Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
[TBL] [Abstract][Full Text] [Related]
18. Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T
Neuroscience; 2009 May; 160(2):484-91. PubMed ID: 19272425
[TBL] [Abstract][Full Text] [Related]
19. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Dajas-Bailador FA; Heimala K; Wonnacott S
Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
[TBL] [Abstract][Full Text] [Related]
20. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence.
Danysz W; Parsons CG
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
